Atlas Trials

Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19

Clinical trial NCT06676709 · COMPLETED

Trial details

NCT number
NCT06676709
Sponsor
Universidad Autonoma de Nuevo Leon
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19SARS-CoV2 Infection
Start date
2021-04-20
Primary completion
2022-02-03
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.